To include your compound in the COVID-19 Resource Center, submit it here.

Levact regulatory update

The U.K.'s NICE issued final guidance recommending the use of Levact bendamustine from Mundipharma as a first-line treatment for patients with

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE